Production (Stage)
Wellgistics Health, Inc.
WGRX
$2.36
-$0.12-4.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6,347.12% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6,347.12% | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 39,045.49% | 309.86% | 99.11% | -61.44% | 2,116.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52,796.99% | 1,422.76% | 721.29% | -70.24% | 2,116.67% |
| Operating Income | -39,183.71% | -253.17% | -93.16% | 56.65% | -2,116.67% |
| Income Before Tax | -38,926.35% | -302.51% | -106.69% | 56.15% | -2,208.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -38,926.35% | -302.51% | -106.69% | 56.15% | -2,208.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38,926.35% | -302.51% | -106.69% | 56.15% | -2,208.33% |
| EBIT | -39,183.71% | -253.17% | -93.16% | 56.65% | -2,116.67% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -32,778.95% | -268.46% | -81.19% | -- | -- |
| Normalized Basic EPS | -32,433.33% | -270.00% | -81.75% | -- | -- |
| EPS Diluted | -32,778.95% | -656.43% | -81.19% | -- | -- |
| Normalized Diluted EPS | -32,433.33% | -270.00% | -81.75% | -- | -- |
| Average Basic Shares Outstanding | 16.09% | 9.09% | 14.17% | -- | -- |
| Average Diluted Shares Outstanding | 16.09% | 9.09% | 14.17% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |